Kala Bio missed the primary endpoint in the study for its treatment of Persistent Corneal Epithelial Defect, an eye defect, and said it would stop development of the drug, called KPI-012. The company ...
GlobalData on MSN
FDA approves Celltrion’s Eydenzelt for eye diseases
Eydenzelt is a vascular endothelial growth factor inhibitor referencing Eylea, which is jointly developed by Regeneron ...
Shares of Kala Bio plummeted Monday after the company said a study of its treatment for Persistent Corneal Epithelial Defect, an eye defect, missed its primary endpoints and it would stop development ...
Researchers have received a $2.2 million grant from the National Institute on Aging of the National Institutes of Health to ...
An opthalmologist, Zainab Akinbode, has advised Nigerians to desist from using substances such as breast milk and urine as remedies to treat eye defects. Dr. Akinbode said such practices could cause ...
New Delhi [India], October 8: Regular eye check-ups play a crucial role in protecting vision and detecting silent eye ...
15d
Full-time plan: scientists have made a breakthrough in the gene therapy of hereditary eye diseases
How the technology of assembling large proteins right inside the cell will help to overcome previously incurable pathologies ...
Eye specialists Dr Pooja Prabhu and Dr Sushmitha Sriganesh explain how regular eye check-ups go beyond improving vision; they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback